Structural basis for rosuvastatin-induced activation of skeletal muscle ryanodine receptor 1
Gunnar Weninger, Steven Reiken, Qi Yuan, Marco C Miotto, Alexander Chang, Yang Liu, Anetta Wronska, Haikel Dridi, Andrew R Marks · 2026
Read Structural basis for rosuvastatin-induced activation of skeletal muscle ryanodine receptor 1 by Gunnar Weninger, Steven Reiken, Qi Yuan, Marco C Miotto, Alexander Chang, Yang Liu, Anetta Wronska, Haikel Dridi, Andrew R Marks (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13635092.txt.
Description
Gunnar Weninger and eight co-authors present a 2026 study on how a cholesterol drug interacts with a muscle channel. Statins lower blood cholesterol, but they can cause muscle pain and, rarely, severe muscle breakdown. The channel, called RyR1, releases calcium inside muscle cells and has been named as a side target of statins. The team used cryo-electron microscopy to picture the channel with the statin rosuvastatin bound.
The drug sat in a single spot inside the channel's pore and held it in its open shape. In the closed shape, parts of the channel itself fill that spot. Two other statins overlap the site in different ways, and one binds at several spots while rosuvastatin binds at one. The authors suggest rosuvastatin's cleaner binding could guide design of statins with fewer muscle side effects.
Catalog record
| CREATOR | Gunnar Weninger, Steven Reiken, Qi Yuan, Marco C Miotto, Alexander Chang, Yang Liu, Anetta Wronska, Haikel Dridi, Andrew R Marks |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |